Clinical Trial Update: Lixisenatide-The Effects on Glucose and Lipid Metabolism in Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update reporting completed results on lixisenatide's effects on glucose and lipid metabolism in Type 2 Diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Lixisenatide (lixisenatide)

Snippet

Sponsor: University of Surrey | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED